Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
MedImmune Ventures: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
MedImmune Ventures
MedImmune Ventures
Active
Website
X
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
May 1, 2016
G1 Therapeutics
$47.0M Series C
Bihua Chen
Catalio Capital
,
Hatteras Venture Partners
,
RA Capital
, Ryan Allis
,
AJU IB Investment
, Cowen Private Investments
,
Eshelman Ventures
, Franklin Templeton
,
Lumira Ventures
,
Mountain Group Partners
, RA Capital Management
,
Rock Springs Capital
,
Tavistock Group
Feb 1, 2015
G1 Therapeutics
$33.0M Series B
Fred Eshelman
, Peter Kolchinsky
Catalio Capital
,
Hatteras Venture Partners
,
RA Capital
, Ryan Allis
,
Boxer Capital
,
Lumira Ventures
,
Mountain Group Partners
Nov 1, 2013
Astria Therapeutics
$32.0M Series B
Jean George
Advanced Technology Ventures
,
OrbiMed
,
Polaris Partners
,
Venrock
,
Clarus Ventures
, SV Health Investors
Oct 1, 2013
G1 Therapeutics
$13.0M Series A
Michael Gutch
Catalio Capital
,
Hatteras Venture Partners
, Ryan Allis
,
Mountain Group Partners
Dec 12, 2012
Cerapedics
$19.0M Series C
CVF
, Sam Wu
NGN Capital
,
OrbiMed
Nov 6, 2012
Ambit Pharmaceuticals
$25.0M Other Equity
David Bonita
Aisling Capital
,
Apposite Capital
,
Forward Ventures
, Gimv
, GrowthWorks
,
Radius Ventures
, Roche Ventures
Nov 1, 2012
AGTC
$38.0M Series B
SR One
, Ed Hurwitz
MPM Capital
, Robert Garland
,
OrbiMed
,
Osage University Partners
,
Tectonic Ventures
, James Barrett
,
Intersouth Partners
,
InterWest Partners
Jul 1, 2012
Coferon
$12.0M Series B
Hatteras Venture Partners
,
Ascent Biomedical Ventures
, Michael Gutch
Digitalis Ventures
Dec 1, 2011
Astria Therapeutics
$8.0M Series A
—
Advanced Technology Ventures
,
OrbiMed
,
Polaris Partners
,
Venrock
,
Clarus Ventures
, Michael Ross
Jun 10, 2011
Ambit Pharmaceuticals
$30.0M Series D
Allan Marchington
Forward Ventures
,
Genechem
, Gimv
, GrowthWorks
,
Horizon Technology Finance
,
NovaQuest Capital Management
,
OrbiMed
,
Perseus-Soros Biopharmaceutical Fund
,
Radius Ventures
, Roche
Apr 1, 2010
Astria Therapeutics
$39.0M Series A
Clarus Ventures
,
MedImmune Ventures
, SV Health Investors
Advanced Technology Ventures
,
OrbiMed
,
Polaris Partners
,
Venrock
Jan 1, 2010
VentiRx Pharmaceuticals
$25.0M Series A
Maggie Flanagan LeFlore
Aisling Capital
,
Alta Partners
,
ARCH Venture Partners
,
Domain Associates
,
Frazier Healthcare Partners
Nov 1, 2007
Ambit Biosciences
$49.0M Series D
—
OrbiMed
, Allan Marchington
,
Avalon Ventures
, Standish Fleming
,
Genechem
, Gimv
,
Horizon Technology Finance
,
Jov-CMDF
, David Mott
,
NovaQuest Capital Management
,
Perseus-Soros Biopharmaceutical Fund
,
Radius Ventures
, Roche
Oct 1, 2006
VaxInnate
$40.0M Series C
New Leaf Venture Partners
Pitango Venture Capital
, Canaan Partners
,
CHL Medical Partners
,
HealthCare Ventures
,
Oxford Bioscience Partners